gordman has completed a huge secondary offering. wow. yet despite -- the stock is up 4.8% since then. secondary behind them. i'm willing to bless it for speculative domestic security. limit orders, please. this seems like a real good one. now, a few tweets, maybe some mail. first, let's start with @shawn dalymd. you want speculative. because oil has come down so much, i understand why someone for a trade would actually buy usa air, but it's not my cup of tea, but you can do it, all right? i'm blessing it. now one from @mr. flytrap. bng food verse hain. both have strong growth. which is a better choice for the i.r.a.? this is a rather amazing group of stocks. both of them just flying, for i.r.a., i'm still going to do bng, reinvest the dividends and you'll do great. no offense to mr. simon who's running hain, doing a great job, too. >>> my daughter wants to buy her first stock. thanks, mom in oakland. huh-uh, no. you want to buy disney for your daughter. my charitable trust has been buying disney, even though we have a nice cash position,

i do not know gordman's. that's my bad. let me do some work. i will come back.do a whole segment, sounded attractive enough. thank you for the call. how about scott in minnesota, please. scott? >> caller: boo-yah from minneapolis. >> like that. >> caller: hey, first let me say thanks for everything you do. >> thank you. >> caller: okay. here's my question. with the price of oil bottoming and energy stocks well off their highs, what do you like better, apache or schlumberger. >> it's a technology company first. i would rather do schlumberger than apache. that thing is too hard to trade. i got a teeshirt, i didn't want to put it on. too wild. tonight's chartist does see a comeback. collins is saying listen, it could go either way but the last few days are something to build on. stay with cramer. >> coming up, can you handle the heat? cramer gets you fired up for a searing hot lightning round. >>> and later, good medicine? medical innovations are helping us fight chronic diseases and live longer lives. could seattle genetics' product pipeline of tumor terminating t